Galileo - Biotech Innovation Fund IM Fonds
123,83
USD
-0,80
USD
-0,64
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Arcellx Inc | US03940C1009 | 9,14% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,04% |
| Krystal Biotech Inc | US5011471027 | 6,92% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,64% |
| BioNTech SE ADR | US09075V1026 | 4,97% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,37% |
| Stoke Therapeutics Inc | US86150R1077 | 4,04% |
| Gilead Sciences Inc | US3755581036 | 3,56% |
| CARsgen Therapeutics Holdings Ltd Ordinary Shares | KYG1996C1006 | 3,30% |
| uniQure NV | NL0010696654 | 3,07% |
| Sonstige | 47,95% |